Revvity debuts discovery automation platforms at SLAS2026
Revvity announced new discovery platforms at SLAS2026, including assay, screening and imaging automation for high-throughput drug discovery workflows.
Evidence notes
- The SLAS2026 slate included Opera Phenix OptIQ, EnVision Nexus One and the AssayMate liquid-handling workstation.
- Revvity positioned the launches around high-throughput workflows spanning early screening, imaging and data-driven discovery.
- AssayMate automated routine plate-based assay preparation while the imaging and detection platforms expanded adjacent discovery workflows.